SIRT1 inhibition could increase the transcriptional activity of p53 which results in the increased expression of several p53 target genes including Bax, Necdin and Gfi-1 in CML CD34+ cells. Here, TP53 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.